Total Payments
$51,790
2024 Payments
$10,447
Companies
16
Transactions
82
Payment Breakdown by Category
Consulting$36,850 (71.2%)
Research$9,547 (18.4%)
Travel$3,307 (6.4%)
Food & Beverage$1,922 (3.7%)
Other$150.00 (0.3%)
Education$14.56 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $36,850 | 10 | 71.2% |
| Unspecified | $9,547 | 14 | 18.4% |
| Travel and Lodging | $3,307 | 18 | 6.4% |
| Food and Beverage | $1,922 | 38 | 3.7% |
| Honoraria | $150.00 | 1 | 0.3% |
| Education | $14.56 | 1 | 0.0% |
Payments by Type
General
$42,243
68 transactions
Research
$9,547
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $12,190 | 5 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $11,624 | 33 | $0 (2019) |
| VERTEX PHARMACEUTICALS INCORPORATED | $10,346 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $8,220 | 1 | $0 (2023) |
| Mallinckrodt LLC | $6,970 | 3 | $0 (2017) |
| Genentech USA, Inc. | $976.65 | 3 | $0 (2022) |
| bluebird bio, Inc. | $483.31 | 7 | $0 (2024) |
| Millennium Pharmaceuticals, Inc. | $300.00 | 1 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $150.00 | 1 | $0 (2021) |
| Incyte Corporation | $149.13 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,447 | 17 | VERTEX PHARMACEUTICALS INCORPORATED ($10,291) |
| 2023 | $8,715 | 9 | AstraZeneca Pharmaceuticals LP ($8,220) |
| 2022 | $6,834 | 6 | SANOFI US SERVICES INC. ($5,830) |
| 2021 | $5,610 | 5 | SANOFI US SERVICES INC. ($5,300) |
| 2020 | $1,083 | 2 | SANOFI US SERVICES INC. ($1,060) |
| 2019 | $8,501 | 2 | Pharmacyclics LLC, An AbbVie Company ($8,501) |
| 2018 | $1,213 | 16 | Pharmacyclics LLC, An AbbVie Company ($1,047) |
| 2017 | $9,388 | 25 | Mallinckrodt LLC ($6,970) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | CASGEVY (Biological) | Consulting Fee | Cash or cash equivalent | $9,240.00 | General |
| Category: SICKLE CELL DISEASE/BETA THALESSEMIA | ||||||
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | CASGEVY (Biological) | Travel and Lodging | In-kind items and services | $62.86 | General |
| Category: SICKLE CELL DISEASE/BETA THALESSEMIA | ||||||
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | CASGEVY (Biological) | Travel and Lodging | In-kind items and services | $54.01 | General |
| Category: SICKLE CELL DISEASE/BETA THALESSEMIA | ||||||
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | CASGEVY (Biological) | Travel and Lodging | In-kind items and services | $15.99 | General |
| Category: SICKLE CELL DISEASE/BETA THALESSEMIA | ||||||
| 12/08/2024 | VERTEX PHARMACEUTICALS INCORPORATED | CASGEVY (Biological) | Food and Beverage | In-kind items and services | $51.00 | General |
| Category: SICKLE CELL DISEASE/BETA THALESSEMIA | ||||||
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $158.46 | General |
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $37.61 | General |
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $33.83 | General |
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $26.29 | General |
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.43 | General |
| 11/15/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $4.95 | General |
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $430.79 | General |
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $91.31 | General |
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $46.80 | General |
| 04/25/2024 | VERTEX PHARMACEUTICALS INCORPORATED | CASGEVY (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: SICKLE CELL DISEASE/BETA THALESSEMIA | ||||||
| 04/15/2024 | bluebird bio, Inc. | LYFGENIA (Drug) | Food and Beverage | In-kind items and services | $143.67 | General |
| Category: sickle-cell | ||||||
| 02/22/2024 | bluebird bio, Inc. | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 09/26/2023 | bluebird bio, Inc. | Zynteglo (Drug) | Food and Beverage | In-kind items and services | $107.59 | General |
| Category: beta-thalassemia | ||||||
| 08/14/2023 | bluebird bio, Inc. | Zynteglo (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: beta-thalassemia | ||||||
| 06/09/2023 | bluebird bio, Inc. | Zynteglo (Drug) | Food and Beverage | In-kind items and services | $42.71 | General |
| Category: beta-thalassemia | ||||||
| 05/29/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $8,220.00 | General |
| 04/12/2023 | bluebird bio, Inc. | Zynteglo (Drug) | Food and Beverage | In-kind items and services | $38.84 | General |
| Category: beta-thalassemia | ||||||
| 04/03/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $110.88 | General |
| Category: Oncology | ||||||
| 02/17/2023 | bluebird bio, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 02/16/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PCYC-1146-IM | Pharmacyclics LLC, An AbbVie Company | $8,501 | 2 |
| PCYC-1140-IM | Pharmacyclics LLC, An AbbVie Company | $1,047 | 12 |
About Dr. David Jacobsohn, MD
Dr. David Jacobsohn, MD is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346200250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Jacobsohn, MD has received a total of $51,790 in payments from pharmaceutical and medical device companies, with $10,447 received in 2024. These payments were reported across 82 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($36,850).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Chicago, IL
- Active Since 03/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1346200250
Products in Payments
- Ibrutinib (Drug) $9,547
- CASGEVY (Biological) $9,445
- UVADEX (METHOXSALEN) STERILE SOLUTION (Drug) $6,970
- Imbruvica (Drug) $2,076
- Zynteglo (Drug) $202.42
- Soliris (Drug) $150.00
- JAKAFI (Drug) $149.13
- LYFGENIA (Drug) $143.67
- Blincyto (Biological) $140.84
- KYMRIAH (Drug) $139.78
- REZUROCK (Drug) $33.45
- Hizentra (Biological) $25.87
- Gamunex-C (Biological) $21.69
- Defitelio (Drug) $20.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Chicago
Alexis Thompson, Md, MD
Pediatric Hematology-Oncology — Payments: $1.6M
Pediatric Hematology-Oncology $1.6M
James Labelle
Pediatric Hematology-Oncology — Payments: $249,251
Pediatric Hematology-Oncology $249,251
Sherif Badawy, Md, MD
Pediatric Hematology-Oncology — Payments: $207,866
Pediatric Hematology-Oncology $207,866
Dr. Loretta Li, M.d, M.D
Pediatric Hematology-Oncology — Payments: $187,559
Pediatric Hematology-Oncology $187,559
Susan Cohn
Pediatric Hematology-Oncology — Payments: $125,685
Pediatric Hematology-Oncology $125,685
Leonard Valentino, M.d, M.D
Pediatric Hematology-Oncology — Payments: $117,453
Pediatric Hematology-Oncology $117,453